Glass-Coated Catheter Inserts Protect against Nosocomial Infection
By HospiMedica International staff writers Posted on 23 Oct 2019 |
Image: Aston researcher preparing a ZnO laced glass rod (Photo courtesy of Aston University).
A phosphate glass compound containing small amounts of zinc oxide (ZnO) can help eradicate the urinary tract infections (UTIs) that plague catheter patients, according to a new study.
To develop the new catheter coating, researchers at Aston University (Birmingham, United Kingdom) heated phosphate-based glass rods (P2O5)50(Na2O)20(CaO)30 in a furnace to over 1,000°C, before slowly cooling them down to room temperature. The rods were then separated into small discs and placed into contact with bacteria in petri dishes. The rods were laced with ZnO in various concentrations order to determine the antimicrobial effects of increasing ionic degradation. They found that while 1 and 3 mol% ZnO decreased glass degradation, a higher dissolution rate was observed for 5 and 10 mol%.
They found that the higher the ZnO concentration, the larger the effect against microorganisms known to cause hospital-acquired infections (HAIs). When in direct contact, the ZnO-doped glasses showed a complete kill within 24 hours against Escherichia coli, and a significant kill rate of methicillin-resistant Staphylococcus aureus (MRSA), with complete kill achieved after 48 hours. Cytotoxic studies showed no toxic effects on the viability of uroepithelial cells. The study was published in the October 2019 issue of Materials Science & Engineering C.
“Zinc oxide coated phosphate glass, inserted into catheters, has to potential to eradicate the most common bacteria in catheter-associated UTI, E.coli and Staphylococcus aureus,” said senior author Richard Martin, PhD, of the School of Engineering and Applied Science. “This is great news for patients requiring catheters, who would be at a much-reduced risk of contracting a potentially life-threatening UTI during a hospital stay. It is also good for healthcare systems, which could save millions in the costs associated with these infections.”
A UTI is an infection involving any part of the urinary system, including urethra, bladder, ureters, and kidney. Among UTIs acquired in the hospital, approximately 75% are associated with a urinary catheter inserted into the bladder through the urethra to drain urine, which are indicated in between 15-25% of hospitalized patients. The most important risk factor for developing a catheter-associated UTI (CAUTI) is prolonged use of the urinary catheter.
Related Links:
Aston University
To develop the new catheter coating, researchers at Aston University (Birmingham, United Kingdom) heated phosphate-based glass rods (P2O5)50(Na2O)20(CaO)30 in a furnace to over 1,000°C, before slowly cooling them down to room temperature. The rods were then separated into small discs and placed into contact with bacteria in petri dishes. The rods were laced with ZnO in various concentrations order to determine the antimicrobial effects of increasing ionic degradation. They found that while 1 and 3 mol% ZnO decreased glass degradation, a higher dissolution rate was observed for 5 and 10 mol%.
They found that the higher the ZnO concentration, the larger the effect against microorganisms known to cause hospital-acquired infections (HAIs). When in direct contact, the ZnO-doped glasses showed a complete kill within 24 hours against Escherichia coli, and a significant kill rate of methicillin-resistant Staphylococcus aureus (MRSA), with complete kill achieved after 48 hours. Cytotoxic studies showed no toxic effects on the viability of uroepithelial cells. The study was published in the October 2019 issue of Materials Science & Engineering C.
“Zinc oxide coated phosphate glass, inserted into catheters, has to potential to eradicate the most common bacteria in catheter-associated UTI, E.coli and Staphylococcus aureus,” said senior author Richard Martin, PhD, of the School of Engineering and Applied Science. “This is great news for patients requiring catheters, who would be at a much-reduced risk of contracting a potentially life-threatening UTI during a hospital stay. It is also good for healthcare systems, which could save millions in the costs associated with these infections.”
A UTI is an infection involving any part of the urinary system, including urethra, bladder, ureters, and kidney. Among UTIs acquired in the hospital, approximately 75% are associated with a urinary catheter inserted into the bladder through the urethra to drain urine, which are indicated in between 15-25% of hospitalized patients. The most important risk factor for developing a catheter-associated UTI (CAUTI) is prolonged use of the urinary catheter.
Related Links:
Aston University
Latest Critical Care News
- GPS-Like Smart Pills with AI Provide Real-Time 3D Monitoring Of Gastrointestinal Health
- Bioengineering Breakthrough to Improve Bone Regeneration Treatments
- Soft Robots with Electronic Skins and Artificial Muscles to Provide Medical Treatment
- AI Camera Technology Helps Doctors Quickly Assess Severity of Infections
- Machine Learning Delivers Personalized Oxygenation for Patients on Ventilators
- New AI Algorithm Detects Rare Epileptic Seizures from EEG Data
- Facial Thermal Imaging Combined with AI Predicts Coronary Artery Disease
- AI Technology Predicts Cardiac Events 10 Years in Advance
- Recyclable ‘Smart Skin’ Monitors Biological Signals on Demand
- Novel Catheter to Reduce Risk for Associated Urinary Tract Infections and Sepsis
- AI Doubles Medical Professionals’ Accuracy in Reading EEG Charts of ICU Patients
- Flexible Device Enables Sweat Gland Stimulation and Simultaneous Biosensing
- WHO Publishes First Global Guidelines to Reduce Bloodstream Infections from Catheter Use
- Innovative Material Paves Way for Next-Generation Wearable Devices
- Wireless Electronic Suture Enables Postoperative Long-Term Monitoring Of Soft Tissue
- Transcatheter Valve Replacement Outcomes Similar To Surgery, Finds Study